By Investors Health | 29th October, 2026
A phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of c...
Read MoreBy Investors Health | 29th October, 2026
Family estrangement experts reveal the subtle warning signs, from skipped holidays to shifted tone, ...
Read MoreBy Investors Health | 28th October, 2026
A former Cornell University student described feeling severe dissociation after taking ketamine befo...
Read MoreBy Investors Health | 28th October, 2026
Eli Lilly's retatrutide cut breathing interruptions and drove significant weight loss in sleep apnea...
Read More
